<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="/resources/spdi-openaccess-jats.xsl"?>
<!DOCTYPE response [
	
<!ENTITY % article SYSTEM "http://jats.nlm.nih.gov/archiving/1.2/JATS-archivearticle1.dtd">
<!ENTITY % book-part-wrapper SYSTEM "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
	]><response><apiMessage>This XML was provided by Springer Nature</apiMessage><query>doi:10.1186/s12951-022-01331-x</query><apiKey>87ba7cb21f89ce78154df796840621f4</apiKey><result><total>1</total><start>1</start><pageLength>2</pageLength><recordsDisplayed>1</recordsDisplayed></result><records><article dtd-version="1.2" article-type="research-article" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="publisher-id">12951</journal-id><journal-title-group><journal-title>Journal of Nanobiotechnology</journal-title><abbrev-journal-title abbrev-type="publisher">J Nanobiotechnol</abbrev-journal-title></journal-title-group><issn pub-type="epub">1477-3155</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">s12951-022-01331-x</article-id><article-id pub-id-type="manuscript">1331</article-id><article-id pub-id-type="doi">10.1186/s12951-022-01331-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Artificial photoactive chlorophyll conjugated vanadium carbide nanostructure for synergistic photothermal/photodynamic therapy of cancer</article-title></title-group><contrib-group><contrib contrib-type="author" id="Au1"><name><surname>Lu</surname><given-names>Huiting</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes" id="Au2"><name><surname>Zada</surname><given-names>Shah</given-names></name><address><email>b20180642@xs.ustb.edu.cn</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="corresp" rid="IDs1295102201331x_cor2">b</xref></contrib><contrib contrib-type="author" id="Au3"><name><surname>Tang</surname><given-names>Songsong</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" id="Au4"><name><surname>Yaru</surname><given-names>Cheng</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" id="Au5"><name><surname>Wei</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" id="Au6"><name><surname>Yuchun</surname><given-names>Qiao</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" id="Au7"><name><surname>Yang</surname><given-names>Qiqi</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au8"><name><surname>Du</surname><given-names>Jinya</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" id="Au9"><name><surname>Fu</surname><given-names>Pengcheng</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes" id="Au10"><name><surname>Dong</surname><given-names>Haifeng</given-names></name><address><email>hfdong@ustu.edu.cn</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="corresp" rid="IDs1295102201331x_cor10">k</xref></contrib><contrib contrib-type="author" corresp="yes" id="Au11"><name><surname>Zhang</surname><given-names>Xueji</given-names></name><address><email>zhangxueji@ustb.edu.cn</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="corresp" rid="IDs1295102201331x_cor11">m</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.69775.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 0369 0705</institution-id><institution content-type="org-division">School of Chemistry and Biological Engineering</institution><institution content-type="org-name">University of Science &amp; Technology Beijing</institution></institution-wrap><addr-line content-type="street">0 Xueyuan Road</addr-line><addr-line content-type="postcode">100083</addr-line><addr-line content-type="city">Beijing</addr-line><country country="CN">People’s Republic of China</country></aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.263488.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 0472 9649</institution-id><institution content-type="org-name">Marshall Laboratory of Biomedical Engineering, Research Center for Biosensor and Nanotheranostic, School of Biomedical Engineering, Shenzhen University</institution></institution-wrap><addr-line content-type="postcode">518060</addr-line><addr-line content-type="city">Guangdong</addr-line><country country="CN">People’s Republic of China</country></aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.69775.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 0369 0705</institution-id><institution content-type="org-division">Beijing Key Laboratory for Bioengineering and Sensing Technology, Research Center for Bioengineering and Sensing Technology, School of Chemistry and Bioengineering</institution><institution content-type="org-name">University of Science &amp; Technology Beijing</institution></institution-wrap><addr-line content-type="postcode">100083</addr-line><addr-line content-type="city">Beijing</addr-line><country country="CN">People’s Republic of China</country></aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.428986.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 0373 6302</institution-id><institution content-type="org-name">State Key Laboratory of Marine Resource Utilization in South China Sea Hainan University</institution></institution-wrap><addr-line content-type="street">58 Renmin Avenue, Meilan District</addr-line><addr-line content-type="postcode">570228</addr-line><addr-line content-type="city">Haikou</addr-line><addr-line content-type="state">Hainan Province</addr-line><country country="CN">People’s Republic of China</country></aff></contrib-group><author-notes><fn fn-type="con"><p>Huiting Lu and Shah Zada contribute equally to this paper</p></fn><corresp id="IDs1295102201331x_cor2"><label>b</label><email>b20180642@xs.ustb.edu.cn</email></corresp><corresp id="IDs1295102201331x_cor10"><label>k</label><email>hfdong@ustu.edu.cn</email></corresp><corresp id="IDs1295102201331x_cor11"><label>m</label><email>zhangxueji@ustb.edu.cn</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>9</day><month>3</month><year>2022</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>12</month><year>2022</year></pub-date><volume>20</volume><issue seq="121">1</issue><elocation-id>121</elocation-id><history><date date-type="registration"><day>3</day><month>3</month><year>2022</year></date><date date-type="received"><day>30</day><month>9</month><year>2021</year></date><date date-type="accepted"><day>25</day><month>2</month><year>2022</year></date><date date-type="online"><day>9</day><month>3</month><year>2022</year></date></history><permissions><copyright-statement content-type="compact">© The Author(s) 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xlink:href="http://creativecommons.org/licenses/by/4.0/" ext-link-type="uri">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link xlink:href="http://creativecommons.org/publicdomain/zero/1.0/" ext-link-type="uri">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><abstract xml:lang="en" id="Abs1"><title>Abstract</title><sec><p id="Par1">Optically active nanostructures consisting of organic compounds and metallic support have shown great promise in phototherapy due to their increased light absorption capacity and high energy conversion. Herein, we conjugated chlorophyll (Chl) to vanadium carbide (V<sub>2</sub>C) nanosheets for combined photodynamic/photothermal therapy (PDT/PTT), which reserves the advantages of each modality while minimizing the side effects to achieve an improved therapeutic effect. In this system, the Chl from <italic>Leptolyngbya JSC-1</italic> extracts acted as an efficient light-harvest antenna in a wide NIR range and photosensitizers (PSs) for oxygen self-generation hypoxia-relief PDT. The available large surface of two-dimensional (2D) V<sub>2</sub>C showed high Chl loading efficiency, and the interaction between organic Chl and metallic V<sub>2</sub>C led to energy conversion efficiency high to 78%. Thus, the Chl/ V<sub>2</sub>C nanostructure showed advanced performance in vitro cell line killing and completely ablated tumors in vivo with 100% survival rate under a single NIR irradiation. Our results suggest that the artificial optical Chl/V<sub>2</sub>C nanostructure will benefit photocatalytic tumor eradication clinic application.</p></sec><sec id="ASec2"><title>Graphical Abstract</title><p><fig id="Figa" position="anchor"><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2022_1331_Figa_HTML.png" position="anchor" id="MO7"/></fig></p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Optically active nanostructures</kwd><kwd>Photothermal therapy</kwd><kwd>Photodynamic therapy</kwd><kwd>Chlorophyll</kwd><kwd>Vanadium carbide</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>Excellent Young Talents Fund Program of Higher Education Institutions of Anhui Province</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">http://dx.doi.org/10.13039/501100005063</institution-id></institution-wrap></funding-source><award-id award-type="FundRef grant">22022407</award-id><principal-award-recipient><name><surname>Dong</surname><given-names>Haifeng</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution-wrap><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id award-type="FundRef grant">21874008</award-id><award-id award-type="FundRef grant">22004006</award-id><principal-award-recipient><name><surname>Dong</surname><given-names>Haifeng</given-names></name></principal-award-recipient><principal-award-recipient><name><surname>Dong</surname><given-names>Haifeng</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution-wrap><institution>Major Program of National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id award-type="FundRef grant">21890740</award-id><award-id award-type="FundRef grant">21890742</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Xueji</given-names></name></principal-award-recipient><principal-award-recipient><name><surname>Zhang</surname><given-names>Xueji</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution-wrap><institution>Special Foundation for State Major Research Program of China</institution></institution-wrap></funding-source><award-id award-type="FundRef grant">Nos.2019YFC1606603</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Xueji</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution-wrap><institution>SZU Top Ranking Project</institution></institution-wrap></funding-source><award-id award-type="FundRef grant">860000002100165</award-id><award-id award-type="FundRef grant">86000000210</award-id><principal-award-recipient><name><surname>Dong</surname><given-names>Haifeng</given-names></name></principal-award-recipient><principal-award-recipient><name><surname>Dong</surname><given-names>Haifeng</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution-wrap><institution>Beijing Municipa Science and Technology Commission</institution></institution-wrap></funding-source><award-id award-type="FundRef grant">z131102002813058</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Xueji</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>publisher-imprint-name</meta-name><meta-value>BioMed Central</meta-value></custom-meta><custom-meta><meta-name>volume-issue-count</meta-name><meta-value>1</meta-value></custom-meta><custom-meta><meta-name>issue-article-count</meta-name><meta-value>121</meta-value></custom-meta><custom-meta><meta-name>issue-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-pricelist-year</meta-name><meta-value>2022</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-holder</meta-name><meta-value>The Author(s)</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-year</meta-name><meta-value>2022</meta-value></custom-meta><custom-meta><meta-name>article-contains-esm</meta-name><meta-value>Yes</meta-value></custom-meta><custom-meta><meta-name>article-numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-year</meta-name><meta-value>2022</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-month</meta-name><meta-value>3</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-day</meta-name><meta-value>3</meta-value></custom-meta><custom-meta><meta-name>article-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>volume-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>journal-product</meta-name><meta-value>ArchiveJournal</meta-value></custom-meta><custom-meta><meta-name>numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-grants-type</meta-name><meta-value>OpenChoice</meta-value></custom-meta><custom-meta><meta-name>metadata-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>abstract-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodypdf-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodyhtml-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bibliography-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>esm-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>online-first</meta-name><meta-value>false</meta-value></custom-meta><custom-meta><meta-name>pdf-file-reference</meta-name><meta-value>BodyRef/PDF/12951_2022_Article_1331.pdf</meta-value></custom-meta><custom-meta><meta-name>pdf-type</meta-name><meta-value>Typeset</meta-value></custom-meta><custom-meta><meta-name>target-type</meta-name><meta-value>OnlinePDF</meta-value></custom-meta><custom-meta><meta-name>issue-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>article-type</meta-name><meta-value>OriginalPaper</meta-value></custom-meta><custom-meta><meta-name>journal-subject-primary</meta-name><meta-value>Chemistry</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Biotechnology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Nanotechnology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Molecular Medicine</meta-value></custom-meta><custom-meta><meta-name>journal-subject-collection</meta-name><meta-value>Chemistry and Materials Science</meta-value></custom-meta><custom-meta><meta-name>open-access</meta-name><meta-value>true</meta-value></custom-meta></custom-meta-group></article-meta><notes notes-type="ESMHint"><title>Supplementary Information</title><p>The online version contains supplementary material available at <ext-link xlink:href="10.1186/s12951-022-01331-x" ext-link-type="doi">https://doi.org/10.1186/s12951-022-01331-x</ext-link>.</p></notes></front><body><sec id="Sec1"><title>Introduction</title><p id="Par24">Cancer is a stressful and dangerous disease because of the maximum occurrence rate in humans and high mortality [<xref ref-type="bibr" rid="CR1">1</xref>]. In the past few years, besides traditional surgery, chemotherapy, and radiotherapy, massive attention has been devoted to discovering non-invasive safe and suitable alternative approaches for this critical disease breakthrough [<xref ref-type="bibr" rid="CR2">2</xref>]. Non-invasive and highly-selective phototherapy typically carried out in photodynamic therapy (PDT) and photothermal therapy (PTT) hold great promise in cancer treatments [<xref ref-type="bibr" rid="CR3">3</xref>]. PDT is a promising tumor ablative therapeutic approach in the field of oncology [<xref ref-type="bibr" rid="CR4">4</xref>]. It depends on the laser-induced ability of photosensitizers (PSs) to transfer energy to oxygen dissolved in the tumor environment to generate cytotoxic singlet oxygen (O<sup>1</sup><sub>2</sub>), which enabled successively causing cell death and mortality of immediate tumor tissues [<xref ref-type="bibr" rid="CR5">5</xref>]. However, the PDT efficiency of solid tumors is mostly unsatisfying by issues involving the hydrophobic and hypoxic tumor microenvironment (TME) [<xref ref-type="bibr" rid="CR6">6</xref>] and limited light penetrability [<xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par25">Photothermal therapy (PTT) has been considered a progressively advanced, safe, and promising therapeutic approach for cancer [<xref ref-type="bibr" rid="CR4">4</xref>]. Near-infrared (NIR) irradiation is regularly applied to produce heat for hyperthermia of tumor spots without damaging normal tissue cells [<xref ref-type="bibr" rid="CR3">3</xref>]. The photothermal conversion agent (PTCA) absorbs light energy as a source and converts it into heat, which significantly determines nanomaterial-based PTT performance [<xref ref-type="bibr" rid="CR8">8</xref>]. Two correlated procedures can clearly and quantitatively define the photothermal ability of PTCA [<xref ref-type="bibr" rid="CR9">9</xref>]. The first procedure mainly concentrated on the absorption of NIR light to obtain energy from irradiation. The value could be fixed by the molar elimination quantity of the materials [<xref ref-type="bibr" rid="CR10">10</xref>]. The second procedure relates to the energy transformation pathways from the absorbed light to heat, generally related to photothermal conversion proficiency [<xref ref-type="bibr" rid="CR11">11</xref>]. Thus, the PTCA agents performed a crucial role in manipulating the photothermal effect of their practical/clinical applications [<xref ref-type="bibr" rid="CR12">12</xref>]. The PTCA agents with superior NIR light absorption capacity and reduced non-thermal radiative conversions are still essential [<xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par26">PTT/PDT synergistic therapy of cancers has attracted great interest. In comparison with a single treatment, the PTT/PDT therapy strategies inherited the advantages of each modality while minimizing its side effects, which thus have resulted in a significantly enhanced therapeutic effect. The appropriate heating by PTT enabled increased blood flow and improved oxygen supply for enhanced PDT, and hyperthermia can also improve PDT-induced damages. PDT can disturb TME conditions and result in increased heat sensitivity of cancer cells. To date, many types of nanomaterials have been employed for dual-modality PTT/PDT [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. The development of optically active nanostructures with extraordinary physicochemical properties to conduct coinciding synergistic PDT/PTT treatment under irradiation is urgently needed [<xref ref-type="bibr" rid="CR16">16</xref>].</p><p id="Par27">Herein, we fabricated a Chl/V<sub>2</sub>C optically active nanostructures by assembling Chl to V<sub>2</sub>C nanosheets (NSs) to realize synergistic PDT/PTT with improved therapeutic effect. The Chl from <italic>Leptolyngbya JSC-1</italic> extract enabled efficient light harvest in a wide NIR range and implemented oxygen self-generation for hypoxia-relief PDT. The two-dimension V<sub>2</sub>C provided a large surface for Chl loading. The interaction between organic Chl and metallic V2C results in high energy conversion and highly-effective photothermal conversion efficiency for PTT. Under NIR irradiation, the Chl/V<sub>2</sub>C nanostructure showed advanced anticancer performance in vitro cell line killing and tumor ablation in vivo. (Scheme <xref rid="Sch1" ref-type="fig">1</xref>). The chlorophyll (Chl) is a green pigment and light-sensitive substance. The chemical formula of (Chl) is C<sub>55</sub>H<sub>72</sub>MgN<sub>4</sub>O<sub>5</sub>. It is automatically activated after the NIR light strikes. It generates a special kind of oxygen molecule or ROS that kills the tumor cells (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Scheme S1). The artificial optical Chl/V<sub>2</sub>C nanostructure holds excellent potential in synergistic PDT/PTT.<fig id="Sch1"><label>Scheme 1</label><caption xml:lang="en"><p>Schematic illustration of Chl/V<sub>2</sub>C nanostructure for synergistic PTT/PDT. Note Because chl is very strong light sensitive and having high potential to convert light energy to thermal energy</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2022_1331_Sch1_HTML.png" id="MO1"/></fig></p></sec><sec id="Sec2" sec-type="materials|methods"><title>Materials and methods</title><sec id="Sec3"><title>Instrument</title><p id="Par28">Transmission electron microscopy (TEM), high-resolution transmission electron microscopy (HRTEM) and energy dispersive X-ray spectroscopy spectra (EDX) were performed on a JEM-2100F transmission electron microscope (HITACHI, Japan). UV–Vis absorption spectra were collected by a UV-3600 Shimadzu UV–Vis spectrometer (Shimadzu, Japan). Fourier transform infrared spectroscopy (FTIR) was performed using a Nicolet 6700 FT-IR spectrometer. The oxygen meter was utilized to measure oxygen concentration generation in solutions (JPBJ-606, INESA, and China). The temperature and thermal images were recorded on an infrared thermal imaging instrument (Fluke TiS65, USA). The Dynamic light scattering (DLS) analysis was used to obtain the size of the synthesized nanosheet (Malvern Instruments Zetasizer Nano ZS90). The confocal laser scanning microscopy (CLSM) images were acquired on the FV1200 microscope (Olympus, Japan).</p></sec><sec id="Sec4"><title>Extraction of Chl</title><p id="Par29">Twenty grams of <italic>Leptolyngbya</italic> JSC-1 were milled in 100 mL of liquid nitrogen with a mortar and pestle for 5 min. The extract was gently shifted to a fresh bottle and washed the crusher thoroughly with acetone. The volume was adjusted exactly to 500 mL by adding acetone to the glass bottle, followed by incubation for 8 h. Then, the extract was filtered using Millipore membrane (0.2 µm pore size) to eliminate contaminations. After filtration, the solution was centrifuged for 10 min at 1500 rpm to collect the supernatant of the solution. The extracted Chl was compared with standard Chl under a UV spectrophotometer [<xref ref-type="bibr" rid="CR17">17</xref>].</p></sec><sec id="Sec5"><title>Green synthesis of V<sub>2</sub>C NSs</title><p id="Par30">The V<sub>2</sub>C NSs were synthesized according to our previous study [<xref ref-type="bibr" rid="CR18">18</xref>]. The powder of V<sub>2</sub>AlC (roughly 100 mg) mixed with a 20 mL solution of algae extract was added into the water with a final volume of 100 mL and stirred for one day at room temperature. The resultant mixture was carefully washed with water and ethanol by centrifugation. The pellet was dispersed in 50 mL of water and stirred for an additional 1 day at room temperature. Then V<sub>2</sub>C NSs were collected by centrifuging at 5000 g for 10 min and washed thrice with ethanol and water to remove the other remains.</p></sec><sec id="Sec6"><title>Fabrication of Chl/V<sub>2</sub>C NSs</title><p id="Par31">20 µL Chl was mixed with V<sub>2</sub>C (5 mg/mL) and sonicated for 30 min to fully incorporate the Chl on the surface of the V<sub>2</sub>C NSs. The resulting Chl/V<sub>2</sub>C was washed three times. The loaded Chl molecules on V2C were investigated with UV–Vis spectroscopy at different intervals of time [<xref ref-type="bibr" rid="CR19">19</xref>].</p></sec><sec id="Sec7"><title>Photothermal performance of the Chl/V<sub>2</sub>C</title><p id="Par32">1 mL Chl/V<sub>2</sub>C aqueous solution with different concentrations (0, 5, 10, 20, 40, and 80 µg / mL, where 0 is the control group) were examined in a quartz cuvette that exposed to an 808 nm laser (0.48 W cm<sup>−2</sup>) for 5 min, following by 10 min natural cooling. To examine the photothermal stability of the samples, repeat five times the heating and cooling cycle. The temperature was observed using a thermocouple at various an interval [<xref ref-type="bibr" rid="CR18">18</xref>].</p></sec><sec id="Sec8"><title>Cell cytotoxicity evaluation</title><p id="Par33">The MCF-7 cells were cultured in Gibco Dulbecco's Modified Eagle Medium (DMEM) medium containing 1% penicillin/streptomycin (P/S) and 10% fetal bovine serum (FBS) at 37 °C and 5% CO<sub>2</sub> in a moist atmosphere. Initially, the MCF-7 cells were seeded in a 96-wells plate for 24 h at a 1 × 10<sup>4</sup> density of cells per well. The cells were treated with control, V<sub>2</sub>C, Chl, and Chl/V<sub>2</sub>C in different concentrations (0, 10, 20, 40, 80, 160 µg / mL) for 4 h. Consequently, the new media were replaced and kept for 24 h again. 10 μL of microculture tetrazolium assay solution was added to each well (5 mg mL<sup>−1</sup> phosphate-buffered saline (PBS) (pH 7.4,10 mM). After the incubation for another 4 h, the cell viability was determined by a microplate reader at 492 nm. For CLSM images, cells were cultured for 24 h. Then the media were replaced with fresh media containing PBS (pH 7.4,10 Mm), V<sub>2</sub>C, Chl, and Chl/V<sub>2</sub>C and incubated for 4 h. Afterward, the cells were stained with dual dyes PI and Cancelin for 10 min and then washed with PBS (pH 7.4,10 Mm) before examining them under a CLSM, according to our previous report [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>].</p></sec><sec id="Sec9"><title>Singlet oxygen generation capability of Chl/V<sub>2</sub>C</title><p id="Par34">The DCFH-DA probe was used to measure the <sup>1</sup>O<sub>2</sub> generation ability of Chl, V<sub>2</sub>C and Chl/V<sub>2</sub>C under NIR laser irradiation. 5 μL of DCFH-DA was added into the solution of Chl (1 mL, 80 μg/ mL), V<sub>2</sub>C nanosheet (1 mL, 80 μg/ mL) and Chl/V<sub>2</sub>C (1 mL, 80 μg/ mL) irradiated with a 670 nm laser (0.48 W cm<sup>−2</sup>) for 5 min. The fluorescence of DCFH-DA at 410 nm was continuously recorded for 10 min and the <sup>1</sup>O<sub>2</sub> dramatic yield was calculated [<xref ref-type="bibr" rid="CR21">21</xref>].</p></sec><sec id="Sec10"><title>In Vitro PTT and PDT therapeutic efficacy</title><p id="Par35">The cells were seeded in confocal dishes for 24 h with a density of 1 × 10<sup>4</sup> cells per well. Cells were treated as follows: PBS (phosphate buffer solution) (pH 7.4,10 mM), Laser (670 &amp; 808 nm), V<sub>2</sub>C (1 mL, 80 μg/ mL), Chl (1 mL, 80 μg/ mL), Chl/V<sub>2</sub>C(1 mL, 80 μg/ mL), Chl/V<sub>2</sub>C (1 mL, 80 μg/ mL) + 670 nm laser, Chl/V<sub>2</sub>C(1 mL, 80 μg/ mL) + 808 nm laser, Chl/V<sub>2</sub>C(1 mL, 80 μg/ mL) + 670 &amp; 808 nm laser (0.48 W cm<sup>−2</sup>). After exposure, the culture media were removed and the cells were thoroughly washed with PBS. For CLSM imaging, all groups were stained using dual dyes Calcein-AM and PI. For intracellular <sup>1</sup>O<sub>2</sub> generation measurement, the cells were incubated in confocal cultured dishes for 24 h and treated as aforementioned for 4 h. Afterward, the media were replaced with fresh DMEM and incubated for another 12 h. Cells were stained with SOSG (2 μL) and Hoechst 33342 for 10 min (2 μL, 2 × 10<sup>−3</sup> m), and then CLSM was used for observing cells.</p></sec><sec id="Sec11"><title>In vivo PTT/PDT</title><p id="Par36">Four to five-week-old Balb/c nude female mice were purchased from Beijing Vital River Laboratory Animal Technology Co, Ltd. All animal experimentations were done following the recommended protocol. 100 μL of PBS (pH 7.4,10 mM) containing 2 × 10<sup>6</sup> MCF-7 cells were subcutaneously inoculated into the back of every mice. The mice were randomly arranged into 8 groups (each containing five mice) when the tumor volume reached 200 mm<sup>3</sup> (<italic>V</italic> = width<sup>2</sup> × length/2). The drug were intravenously injected/treated into the tail vein of mice as follows: (1) PBS (pH 7.4,10 mM), (2) Laser (670 &amp; 808 nm), (3) Chl/V<sub>2</sub>C (1 mL, 80 μg/ mL) (4) Chl (1 mL, 80 μg/ mL) + 670 nm laser, (5) V<sub>2</sub>C (1 mL, 80 μg/ mL) + 808 nm laser, (6) Chl/V<sub>2</sub>C (1 mL, 80 μg/ mL) + 670 nm laser, (7) Chl/V<sub>2</sub>C (1 mL, 80 μg/ mL) + 808 nm laser and (8) Chl/V<sub>2</sub>C (1 mL, 80 μg/ mL) + 670 &amp; 808 nm laser irradiation for 5 min (0.48 W cm<sup>−2</sup>), respectively. The tumor volume and body weight were measured at intervals of 3 days for 2 weeks. For histological analysis, principal organs and tumor tissues were collected [<xref ref-type="bibr" rid="CR18">18</xref>].</p></sec><sec id="Sec12"><title>The blood circulation and biodistribution of Chl/V<sub>2</sub>C NSs</title><p id="Par37">MCF-7 cells were introduced to mice follow the above method. The MCF-7 tumors mice were treated intravenously with Chl/V2C NSs (10 mg/kg). After intravenous injection the (50 µL) blood samples were collected from the eye socket at 0.5, 1, 3, 6, and 12 h (<italic>n</italic> = 5) of each interval respectively. The collected blood sample were treated with H<sub>2</sub>O<sub>2</sub>/HNO<sub>3</sub> solution (1:3) and Mg/V concentrations were measured by ICP-MS, which devoted Chl/V<sub>2</sub>C NSs. The tumor-bearing mice were sacrificed after 12 h of injection. To evaluate the distribution of Chl/V<sub>2</sub>C NSs in the various tissue/organs, such like (heart, liver, spleen, lung, kidney, and tumor were collected, weighed, and dissolved with H<sub>2</sub>O<sub>2</sub>/HNO<sub>3</sub> mixture solution (1:3), and measured the Mg/V concentration using ICP-MS and Mg/V concentrations were measured by ICP-MS, which devoted Chl/V<sub>2</sub>C NSs. Under license no, all animal protocols were approved by the institutional animal ethics review committee of the Peaking University Health Science Center. SYXK (京)-2016–0010.</p></sec><sec id="Sec13"><title>In vitro hypoxic investigation</title><p id="Par38">The cells were incubated in PBS and DMEM media containing Chl/V<sub>2</sub>C (1 mL, 80 μg/ mL) in confocal dishes along with or without laser 670 (0.48 W cm<sup>−2</sup>) irradiation for 10 min individually, keeping for 4 h. Afterward, all the groups were shifted to a translucent box and exposed to N<sub>2</sub> atmosphere. Successively, the cells media were replaced with fresh media and incubated for 24 h. Then cells were examined under the confocal microscope [<xref ref-type="bibr" rid="CR21">21</xref>].</p></sec><sec id="Sec14"><title>Tumour model hypoxia measuring</title><p id="Par39">Again MCF-7 cell inserted intravenously to mice like above. And growth of tumour was monitored until it reached the size of 200 mm<sup>3</sup> (<italic>V</italic> = width<sup>2</sup> × length/2). Then, Chl/V<sub>2</sub>C SNs (10 mg/kg-1) was injected into the mice via the tail vein After 24 h, the mice were irradiated with a 670 &amp; 808 nm laser irradiation for 5 min (0.48 W cm<sup>−2</sup>) Then, the mice were injected intraperitoneally with saline solution containing pimonidazole hydrochloride (60 mg/kg). After 1 h, the mice were scarified and the tumor tissues were harvested. For immunofluorescence staining, the tumor hypoxia regions were labeled with FITC-MBb1 (antipimonidazole antibody). Next, the slices were stained with an anti-FITC secondary antibody and to determine the % hpoxia were measured subsequent analyses by using CLSM [<xref ref-type="bibr" rid="CR21">21</xref>].</p></sec><sec id="Sec15"><title>Statistical analysis</title><p id="Par40">The data were analyzed and demonstrated as the mean, standard deviations (SD), and experimental triplicates for statistical significance.</p></sec></sec><sec id="Sec16"><title>Results and discussion</title><sec id="Sec17"><title>Characterization of Chl/V<sub>2</sub>C</title><p id="Par41">The UV–Vis spectrum of extracted Chl showed two characteristic solid peaks at 433 and 662 nm, similar to the standard sample of Chl (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S1A), which confirmed the successful extraction of Chl from algae extracts [<xref ref-type="bibr" rid="CR22">22</xref>]. The functionalization of V<sub>2</sub>C NSs with Chl appeared two new strong peaks at 453 and 735 nm (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S1B). The red-shift of both peaks compared to the Chl resulted from the interaction between the metallic V<sub>2</sub>C NSs and organic Chl. The intensity of the peaks increased along with the increase of incubated time until 15 min (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S1C), and the maximum loading efficiency was calculated to 10 µg, suggesting good loading efficiency. The V<sub>2</sub>C NSs were successfully exfoliated into a single-layer structure [<xref ref-type="bibr" rid="CR18">18</xref>]. The V<sub>2</sub>C, Chl and Chl/V<sub>2</sub>C Zeta potential anlysis were investgated in (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S2) They showed a narrow size distribution with a mean size of 50–70 nm (Fig. <xref rid="Fig1" ref-type="fig">1</xref>A). The fast Fourier transform (FFT) pattern indicated a hexagonal structure of the crystalline lattice of V<sub>2</sub>C NSs, confirming the well-crystallized nature and successful synthesis of V<sub>2</sub>C NSs (Fig. <xref rid="Fig1" ref-type="fig">1</xref>B). The surface V<sub>2</sub>C NSs was decorated with many Chl nanoparticles with a size of about 30 nm after modifying Chl (Fig. <xref rid="Fig1" ref-type="fig">1</xref>C). The zeta potential of Chl/V<sub>2</sub>C NS showed a significant decrease to -19.5 mV compared with pure V<sub>2</sub>C NSs after negatively charged Chl loading (Fig. <xref rid="Fig1" ref-type="fig">1</xref>D). The remarkable changes in the surface charges advocated the successful assembly of Chl/V<sub>2</sub>C NS. The elemental mapping of V<sub>2</sub>C NSs, Chl and Chl/V<sub>2</sub>C NSs confirmed the successful fabrication of Chl/V<sub>2</sub>C NSs (Fig. <xref rid="Fig1" ref-type="fig">1</xref>E and Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S3). The FT-IR spectra of Chl/V<sub>2</sub>C NSs presented the characteristic peaks derived from both Chl and (Fig. <xref rid="Fig1" ref-type="fig">1</xref>F), validating further the successful assembly of Chl/V<sub>2</sub>C NSs.<fig id="Fig1"><label>Fig. 1</label><caption xml:lang="en"><p><bold>A</bold> TEM images and <bold>B</bold> FFT pattern of V<sub>2</sub>C, <bold>C</bold> TEM images of Chl/V<sub>2</sub>C, <bold>D</bold> Zeta potential, <bold>E</bold> Element mapping and <bold>F</bold> FTIR of Chl, V<sub>2</sub>C, and Chl/V<sub>2</sub>C</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2022_1331_Fig1_HTML.png" id="MO2"/></fig></p></sec><sec id="Sec18"><title>Photothermal performance and ROS generation ability of Chl/V<sub>2</sub>C SNs</title><p id="Par42">The O<sub>2</sub> generation ability of Chl/V<sub>2</sub>C NSs under NIR irradiation through water splitting was validated in (Fig. <xref rid="Fig2" ref-type="fig">2</xref>A), which was beneficial to relieve hypoxic tumor microenvironment (TME) for enhanced PDT performance [<xref ref-type="bibr" rid="CR23">23</xref>]. The ROS production of Chl/V<sub>2</sub>C NSs was investigated using a fluorescent probe, where the 2, 7-Dichloro fluorescein diacetate (DCFH-DA) probes were oxidized to produce green fluorescence (Fig. <xref rid="Fig2" ref-type="fig">2</xref>B). The intensity of DCFH-DA fluorescence displayed a constant increase in Chl/V<sub>2</sub>C NSs solution under a 670 nm laser irradiation (0.48 W/cm<sup>2</sup>) for 10 min. Enhanced ROS generation ability of Chl/V<sub>2</sub>C was observed compared to V<sub>2</sub>C and Chl (Fig. <xref rid="Fig2" ref-type="fig">2</xref>C). The ROS production was further characterized by (ESR) electron spin resonance. It demonstrated that Chl/V<sub>2</sub>C improved generation ability for several types of ROS species, including <sup>1</sup>O<sub>2</sub>, ·OH and·O<sub>2</sub><sup>−</sup> (Fig. <xref rid="Fig2" ref-type="fig">2</xref>D–F). The advanced ROS generation ability was resulted from the interaction between the V<sub>2</sub>C NSs and Chl to enhance photogenerated electron sets parting efficiency at the edge. The chlorophyll has 2-carboxylic acid moiety, in which N-linked to a pyridine dicarboxylic acid group through an acetyl group. The conjugated bonds in these ring systems are responsible for absorbing visible light in the green region. As seen from its structure, it has several carboxylic acid groups, promising good dipole interactions with V<sub>2</sub>C SNs and strong attaching, and a good choice for photo-sensitizer [<xref ref-type="bibr" rid="CR20">20</xref>]. Chl/V2C NSs' good conductivity at the border maintained the electron transmission and reserved the recombined electron [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR24">24</xref>].<fig id="Fig2"><label>Fig. 2</label><caption xml:lang="en"><p><bold>A</bold> O<sub>2</sub> generation of Chl/V<sub>2</sub>C (80 µg/mL) aqueous solution under a 670 nm laser (0.48 W/cm<sup>2</sup>) irradiation. <bold>B</bold> ROS generation Chl/V<sub>2</sub>C (80 µg/mL) measured by DCFH-DA probe under a 670 nm laser (0.48 W/cm<sup>2</sup>). <bold>C</bold> The comparsion of ROS generation of PBS (pH 7.4,10 Mm), V<sub>2</sub>C, Chl and Chl/V<sub>2</sub>C (80 µg/mL) under a 670 nm laser irradiation (0.48 W/cm<sup>2</sup>) monitored by DCFH fluorescence probe. ESR spectra of V<sub>2</sub>C, Chl and Chl/V<sub>2</sub>C (80 µg/mL) under a 670 nm laser (0.48 W/cm<sup>2</sup>) irradiation for characterization of <bold>D</bold><sup>1</sup>O<sub>2</sub>, <bold>E</bold>·OH and <bold>F</bold>·O<sub>2</sub><sup>−</sup>. <bold>G</bold> The UV–vis absorption spectra, <bold>H</bold> photothermal heating curves of Chl/V<sub>2</sub>C with various concentrations and photostability of Chl/V<sub>2</sub>C (80 µg/mL) irradiated by a 808 nm laser (0.8 W/cm<sup>2</sup>) irradiation</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2022_1331_Fig2_HTML.png" id="MO3"/></fig></p><p id="Par43">The Chl/V<sub>2</sub>C SNs presented a strong absorption in the wide NIR range (Fig. <xref rid="Fig2" ref-type="fig">2</xref>G), which showed a concentration-dependent increase in temperature under irradiation. The temperature of Chl/V<sub>2</sub>C SNs NSs (80 µg/mL) improved to 73.2 ℃. In contrast, the control temperature only increased to 29.2 ℃ under irradiation for 10 min (Fig. <xref rid="Fig2" ref-type="fig">2</xref>H) [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. The different ratios of Chl loading in V<sub>2</sub>C nanosheets were investigated. As a result, the greatest phototherapy transfer efficiency and singlet oxygen production efficiency were obtained (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S4). The photothermal conversion efficiency (PTCE) was measured to 78% (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S4) derived from the cooling curve, which was stronger to other 2D PTAs nanomaterials including MoS<sub>2</sub> NSs (24.37) [<xref ref-type="bibr" rid="CR26">26</xref>] V<sub>2</sub>C (47.5%)[<xref ref-type="bibr" rid="CR18">18</xref>] Ti<sub>3</sub>C<sub>2</sub>/g-C<sub>3</sub>N<sub>4</sub> NSs (40.8%) [<xref ref-type="bibr" rid="CR21">21</xref>] and Ti<sub>3</sub>C<sub>2</sub>@Met@CP (59.6%)[<xref ref-type="bibr" rid="CR27">27</xref>]. The high PTCE was because of Chl/V<sub>2</sub>C enhanced light absorption capacity and high energy conversion efficiency [<xref ref-type="bibr" rid="CR28">28</xref>]. The Chl/V<sub>2</sub>C NSs also demonstrated excellent photothermal stability under a 808 nm laser (0.48 W/cm<sup>2</sup>) irradiation for 5 min, with on &amp; off laser cycles for five times (Fig. <xref rid="Fig2" ref-type="fig">2</xref>I).</p></sec><sec id="Sec19"><title>In vitro anticancer performance of Chl/V<sub>2</sub>C NSs and their biosafety analysis</title><p id="Par44">MTT was used to investigate the cytotoxicity of Chl/V<sub>2</sub>C NSs, the viability of MCF-7 cells were still beyond 98% even at a concentration higher than 160 µg/mL, validating the little cytotoxicity of Chl/V<sub>2</sub>C NSs compared to control, Chl and V<sub>2</sub>C (Fig. <xref rid="Fig3" ref-type="fig">3</xref>A), [<xref ref-type="bibr" rid="CR29">29</xref>] which also be validated by the Calcein-AM/PI dual-stained analysis (Fig. <xref rid="Fig3" ref-type="fig">3</xref>B). The low cytotoxicities of Chl/V<sub>2</sub>C NSs towards HeLa and A549 were also validated (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S6). These results concluded the excellent biocompatibility of Chl/V<sub>2</sub>C NSs because chlorophyll is a natural green active pigment and Chl/V<sub>2</sub>C biocompatibility is more superior to other reported materials such as V<sub>2</sub>C, Mo<sub>2</sub>C, Ti<sub>2</sub>C and Ti<sub>3</sub>C. As shown in (Fig. <xref rid="Fig3" ref-type="fig">3</xref>C), the Chl/V<sub>2</sub>C NSs presented good transfection efficiency for cells (endocytosis), further confirmed by the ICP-MS analysis (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S7 A), which is helpful for high-effective therapeutics. Before investigating the anticancer effect of Chl/V<sub>2</sub>C NSs, the intracellular singlet O<sub>2</sub> production ability was studied with a green hypoxia probe. The strong green fluorescence was observed in Chl/V<sub>2</sub>C NSs-treated cells under NIR irradiation (Fig. <xref rid="Fig3" ref-type="fig">3</xref>D), which suggested its good singlet oxygen generation ability, vital for hypoxia (cell death due to oxygen deficiency) in cancerous cells PDT.<fig id="Fig3"><label>Fig. 3</label><caption xml:lang="en"><p><bold>A</bold> Cytotoxicity of MCF-7 cells treated with PBS (pH 7.4,10 Mm), V<sub>2</sub>C, Chl and Chl/V<sub>2</sub>C (80 µg/mL), <bold>B</bold> CLSM of live/dead Calcein AM/PI staining of MCF-7 cells with different treatments, <bold>C</bold> CLSM images of Chl/V<sub>2</sub>C-treated MCF-7 cells for different time (scale bar = 10 μm), <bold>D</bold> Hypoxic level of PBS (pH 7.4,10 Mm) and Chl/V<sub>2</sub>C NSs (80 µg/mL) treated MCF-7 cells with N<sub>2</sub> treatment irradiated with (+) /without (−) laser (scale bar = 100 nm). <bold>E</bold> MTT and <bold>F</bold> Calcein AM/PI staining anlysis of MCF-7 cells with different treatments</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2022_1331_Fig3_HTML.png" id="MO4"/></fig></p><p id="Par45">To comprehensively study the tumor cell killing ability of Chl/V<sub>2</sub>C NSs, the experiments were divided into eight groups as follows: (1) control PBS (pH 7.4,10 Mm) (2) laser 670 &amp; 808 nm, (3) Chl/V<sub>2</sub>C NSs (4) Chl + 670 nm laser, (5) V<sub>2</sub>C NSs + 808 nm laser, (6) Chl/V<sub>2</sub>C NSs + 670 nm laser, (7) Chl/V<sub>2</sub>C NSs + 808 nm laser and (8) Chl/V<sub>2</sub>C NSs + 670 &amp; 808 nm, respectively. Group 1, 2 and 3 showed negligible antitumor ability, and the increase in antitumor ability was observed for group 4–8 (group 4 &lt; 5 &lt; 6 &lt; 7 &lt; 8). The cell viabilities from group 1 to 8 was 99.2, 97, 92, 65, 50, 36, 20 and 1%, respectively (Fig. <xref rid="Fig3" ref-type="fig">3</xref>E). It indicated that the Chl and V2C could mediate PDT (group 4) and PTT (group 5). At the same time, the Chl/V<sub>2</sub>C NSs displayed enhanced therapeutic effects even under single laser irradiation (group 6 and group 7) due to the interaction between Chl and V<sub>2</sub>C. Under 670 and 808 nm laser irradiation, the Chl/V<sub>2</sub>C NSs prevented almost all tumors due to the synergistic effect. The results of Calcein-AM/PI dual-stained analysis were consistent with the cell viabilities analysis. (Fig. <xref rid="Fig3" ref-type="fig">3</xref>F). The intracellular quantification analysis of Chl/V<sub>2</sub>C at different intervals of time (1, 2, 3, 4 &amp; 5 h), the quantification analysis of hypoxia with PBS and Chl/V<sub>2</sub>C, biodistribution and blood circulation of Mg concentrations measured with ICP-MS after injection of Chl/V<sub>2</sub>C to MCF-7 tumor-bearing mice (Mg being devoted by Chlorophyll) were investigated (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Figs. S7 and S8). The hypoxia condition in the tumor before and after treatment has been analyzed and shown in (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S9). These outcomes established the advanced in vitro antitumor capability of Chl/V<sub>2</sub>C NSs.</p></sec><sec id="Sec20"><title>In vivo anticancer performance of Chl/V<sub>2</sub>C NSs</title><p id="Par46">The in vivo cancer therapeutic effect of Chl/V<sub>2</sub>C NSs was studied using mice exgrafed MCF-7 tumors. After intravenous inoculation of Chl/V<sub>2</sub>C NSs for 24 h, mice's main organs and tumors were collected to examine under ICP-MS (Fig. <xref rid="Fig4" ref-type="fig">4</xref>A). High accumulation of Chl/V<sub>2</sub>C NSs (∼30% ID/g) were detected due to the enhanced permeation retention effect and maintenance effect. High-level Chl/V<sub>2</sub>C NSs in the lungs and liver suggested that it could be fast cleared from the other main organs. The blood circulation in Chl/V<sub>2</sub>C NSs-treated samples were regulated in a two-compartment model. The half time was calculated to be 1.49 h, which highly stimulated and increased accumulation efficacy at the tumor site for therapy (Fig. <xref rid="Fig4" ref-type="fig">4</xref>B). The in vivo treatments were divided into 8 groups (n = 5): group (1) Control group PBS (pH 7.4, 10 mM), (20 mg/kg) (2) Laser 670 &amp; 808 nm (3) Chl/V<sub>2</sub>C NSs (4) Chl + 670 nm, (5) V<sub>2</sub>C NSs + 808 nm, (6) Chl/V<sub>2</sub>C NSs + 670 nm, (7) Chl/V<sub>2</sub>C NSs + 808 nm and (8) Chl/V<sub>2</sub>C NSs, + 670 &amp; 808 nm for 5 min laser (0.48 W cm<sup>−2</sup>). The weight of all the groups showed little difference, indicating the good biocompatibility of the Chl/V<sub>2</sub>C (Fig. <xref rid="Fig4" ref-type="fig">4</xref>C). The tumor volume (Fig. <xref rid="Fig4" ref-type="fig">4</xref>D and E) and tumor weight (Fig. <xref rid="Fig4" ref-type="fig">4</xref>F) of mice were monitored after treatment to estimate the therapeutic effect of each group. Group 1, 2, and 3 showed few therapeutic effects. Group 4 and group 5 displayed anticancer effects resulting from Chl-related PDT and V<sub>2</sub>C NSs-mediated PTT. The Chl/V<sub>2</sub>C NSs presented enhanced PDT (group 6) and PDT (group 7) compared to the Chl and V<sub>2</sub>C alone due to the interaction between Chl and V<sub>2</sub>C, which improved the high light absorption and energy conversion efficiency. Group 8 showed complete resistance to tumor growth, and the tumor almost disappeared after 12 days due to combined PTT &amp; PDT. These results demonstrated the good in vivo anticancer ability of Chl/V<sub>2</sub>C NSs [<xref ref-type="bibr" rid="CR30">30</xref>].<fig id="Fig4"><label>Fig. 4</label><caption xml:lang="en"><p><bold>A</bold> Biodistribution and <bold>B</bold> Blood circulation of V concentrations measured with ICP-MS after injection of Chl/V<sub>2</sub>C to MCF-7 tumor-bearing mice, <bold>C</bold> Body weight, <bold>D</bold> relative tumor volume curves, <bold>E</bold> digital images, <bold>F</bold> tumor weight analysis of MCF-7 tumor-bearing mice with different treatment (<italic>n</italic> = 5 mice per group)</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2022_1331_Fig4_HTML.png" id="MO5"/></fig></p></sec><sec id="Sec21"><title>Biological biosafety analysis of Chl/V<sub>2</sub>C NSs</title><p id="Par47">The hematoxylin–eosin (H&amp;E) staining analysis of the key organs containing (spleen, kidney, lungs, liver, &amp; heart) were conducted after the mice received treatment for two weeks. As shown in (Fig. <xref rid="Fig5" ref-type="fig">5</xref>A), no significant damage was detected in all main organs after comparing all groups, which illustrates the good in vivo biocompatibility of Chl/V<sub>2</sub>C NSs. (Fig. <xref rid="Fig5" ref-type="fig">5</xref>B) showed the H&amp;E, TUNEL, and Ki—67 staining analysis, which indicated the tumor cells were not damaged in (1, 2 &amp; 3) control groups. Groups 4 and 5 depicted fragmentary or little necrosis, while groups 6 and 7 demonstrated significant necrosis (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Fig. S10). The highest percentage of necrosis occurred in cancer cells of group 8, illustrating the excellent antitumor efficiency of Chl/V<sub>2</sub>C NSs. The in vivo toxicity was further studied after systemic administration of Chl/V<sub>2</sub>C NSs via intravenous injection. The normal blood biochemical profiling was done and multipurpose markers such as total bilirubin <bold>(</bold>TBL<bold>),</bold> aspartate aminotransferase (AST), alanine aminotransferase (ALT), blood urea nitrogen (BUN), globulin (GLOB), total protein (TP), creatinine (CREA), and albumin (ALB) were measured. (Fig. <xref rid="Fig5" ref-type="fig">5</xref>C-J) demonstrated that mice treated with Chl/V<sub>2</sub>C NSs exhibited abnormality compared to all groups, suggesting good compatibility of Chl/V<sub>2</sub>C NSs. [<xref ref-type="bibr" rid="CR31">31</xref>]<fig id="Fig5"><label>Fig. 5</label><caption xml:lang="en"><p><bold>A</bold> The H&amp;E staining analysis of the key organs, including lung, liver, kidney, spleen, and heart, obtained after treatments (scale bar = 100 nm). <bold>B</bold> Pathological changes in tumor tissues were demonstrated with H&amp;E, TUNEL, and Ki67 staining (scale bar = 50 μm). <bold>C</bold>–<bold>J</bold> Biochemistry results of serum obtained from mice after injecting with PBS (pH 7.4,10 mM) and Chl/V<sub>2</sub>C (20 mg/kg) at 24 h. The blood intensities include TP, AST, ALT, BUN, TBL, ALB, and CREA</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/12951_2022_1331_Fig5_HTML.png" id="MO6"/></fig></p></sec></sec><sec id="Sec22" sec-type="conclusions"><title>Conclusion</title><p id="Par48">In summary, we developed an optically active nanostructure of Chl/V<sub>2</sub>C NSs by modifying natural Chl derived from <italic>Leptolyngbya JSC-1</italic> extracts onto the surface of the V<sub>2</sub>C NSs for combined PTT and PDT. The interaction between organic Chl and metallic V<sub>2</sub>C sharply enhanced the light absorption and energy conversion efficiency. In this system, the Chl was used as a light-harvest antenna and PSs, while the V<sub>2</sub>C provided a large surface for Chl loading and acted as PTCAs. The Chl/V<sub>2</sub>C enabled O<sub>2</sub> generation to relieve hypoxic TME and displayed improved ROS species generation ability, including <sup>1</sup>O<sub>2</sub>, ·OH and·O<sub>2</sub><sup>−</sup> for PDT. It also showed a PTCE high of 78%, superior to most of the previous 2D PTCAs. We demonstrated the advanced anticancer effect of the Chl/V<sub>2</sub>C both in vitro and in vivo, and the tumor growth was inhibited entirely after Chl/V<sub>2</sub>C-mediated combined PTT/PDT. Our results suggest that the Chl/V<sub>2</sub>C holds excellent promise for phototherapy and paves a new way to design artificial optical nanostructure for phototherapy rationally.</p></sec></body><back><ack><title>Acknowledgements</title><p>This research was supported by the university of science and technology Beijing and Chancellors scholarship for an International student of USTB.</p></ack><sec sec-type="author-contribution"><title>Authors’ contributions</title><p>SZ: Conceptualization, Methodology, Formal analysis, Investigation, Writing – original draft, Visualization. ST: Conceptualization, Validation, Writing, editing. CY: Formal analysis, Investigation. WW, &amp; QY: Interpretation of data, acquisition. QY, &amp; JD: Methodology, Formal analysis, editing. HL and PF: Resources, Validation, and support. HD and XZ: Conceptualization, Resources, Supervision, Validation, Project administration, Funding acquisition, Writing—review &amp; editing. All authors read and approved the final manuscript.</p></sec><sec><title>Funding</title><p>The project has received funds from the Excellent Young Scientists Fund (22022407), National Natural Science Foundation of China (21874008, 22004006), the work was also supported by the Major Program of National Natural Science Foundation of China (21890740 and 21890742) and Special Foundation for State Major Research Program of China (Grant Nos.2019YFC1606603), SZU Top Ranking Project (860000002100165,86000000210) and Beijing Municipal Science and Technology Commission (Grant No. z131102002813058).</p></sec><sec sec-type="data-availability"><title>Availability of data and materials</title><p>The current study data are available from the corresponding author on reasonable request.</p></sec><sec sec-type="ethics-statement"><title>Declarations</title><sec id="FPar1" sec-type="COI-statement"><title>Competing interests</title><p id="Par49">All authors declare no competing financial interests.</p></sec></sec><ref-list id="Bib1"><title>References</title><ref-list><ref id="CR1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y-H</given-names></name><name><surname>Li</surname><given-names>J-Q</given-names></name><name><surname>Shi</surname><given-names>J-F</given-names></name><name><surname>Que</surname><given-names>J-Y</given-names></name><name><surname>Liu</surname><given-names>J-J</given-names></name><name><surname>Lappin</surname><given-names>JM</given-names></name><name><surname>Leung</surname><given-names>J</given-names></name><name><surname>Ravindran</surname><given-names>AV</given-names></name><name><surname>Chen</surname><given-names>W-Q</given-names></name><name><surname>Qiao</surname><given-names>Y-L</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Bao</surname><given-names>YP</given-names></name></person-group><article-title xml:lang="en">Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies</article-title><source>Mol Psychiatry</source><year>2020</year><volume>7</volume><fpage>1487</fpage><lpage>1499</lpage><pub-id pub-id-type="doi">10.1038/s41380-019-0595-x</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>X</given-names></name><name><surname>Ding</surname><given-names>S</given-names></name><name><surname>Shi</surname><given-names>Q</given-names></name><name><surname>Lyu</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Dong</surname><given-names>W-J</given-names></name><name><surname>Du</surname><given-names>M</given-names></name><name><surname>Dutta</surname><given-names>P</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Du</surname><given-names>D</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Eyeball-like yolk-shell bimetallic nanoparticles for synergistic photodynamic-photothermal therapy</article-title><source>ACS Appl Bio Mater</source><year>2020</year><volume>3</volume><fpage>5922</fpage><lpage>5929</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXhtlegsrrF</pub-id><pub-id pub-id-type="doi">10.1021/acsabm.0c00624</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amendoeira</surname><given-names>A</given-names></name><name><surname>García</surname><given-names>LR</given-names></name><name><surname>Fernandes</surname><given-names>AR</given-names></name><name><surname>Baptista</surname><given-names>PV</given-names></name></person-group><article-title xml:lang="en">Light irradiation of gold nanoparticles toward advanced cancer therapeutics</article-title><source>Adv Therap</source><year>2019</year><volume>3</volume><fpage>1900153</fpage><pub-id pub-id-type="doi">10.1002/adtp.201900153</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Lovell</surname><given-names>JF</given-names></name><name><surname>Yoon</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name></person-group><article-title xml:lang="en">Clinical development and potential of photothermal and photodynamic therapies for cancer</article-title><source>Nat Rev Clin Oncol</source><year>2020</year><volume>11</volume><fpage>657</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1038/s41571-020-0410-2</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahu</surname><given-names>A</given-names></name><name><surname>Kwon</surname><given-names>I</given-names></name><name><surname>Tae</surname><given-names>G</given-names></name></person-group><article-title xml:lang="en">Improving cancer therapy through the nanomaterials-assisted alleviation of hypoxia</article-title><source>Biomaterials</source><year>2020</year><volume>228</volume><fpage>119578</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXitVOgt7%2FO</pub-id><pub-id pub-id-type="doi">10.1016/j.biomaterials.2019.119578</pub-id></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soliman</surname><given-names>N</given-names></name><name><surname>Gasser</surname><given-names>G</given-names></name><name><surname>Thomas</surname><given-names>CM</given-names></name></person-group><article-title xml:lang="en">Incorporation of Ru(II) polypyridyl complexes into nanomaterials for cancer therapy and diagnosis</article-title><source>Adv Mater</source><year>2020</year><volume>32</volume><fpage>2003294</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXitV2lsb%2FN</pub-id><pub-id pub-id-type="doi">10.1002/adma.202003294</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>B</given-names></name><name><surname>Situ</surname><given-names>B</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Zheng</surname><given-names>LM</given-names></name></person-group><article-title xml:lang="en">Fabrication of polymeric micelles with aggregation-induced emission and forster resonance energy transfer for anticancer drug delivery</article-title><source>Bioconjug Chem</source><year>2017</year><volume>28</volume><fpage>1944</fpage><lpage>1954</lpage><pub-id pub-id-type="doi">10.1021/acs.bioconjchem.7b00274</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Idiago-López</surname><given-names>J</given-names></name><name><surname>Moreno-Antolín</surname><given-names>E</given-names></name><name><surname>de la Fuente</surname><given-names>JM</given-names></name><name><surname>Fratila</surname><given-names>RM</given-names></name></person-group><article-title xml:lang="en">Nanoparticles and bioorthogonal chemistry joining forces for improved biomedical applications</article-title><source>Nanoscale Adv</source><year>2021</year><volume>3</volume><fpage>1261</fpage><pub-id pub-id-type="doi">10.1039/D0NA00873G</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Xiang</surname><given-names>Y</given-names></name><name><surname>Pan</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Tang</surname><given-names>B</given-names></name></person-group><article-title xml:lang="en">Dual-targeted photothermal agents for enhanced cancer therapy</article-title><source>Chem Sci</source><year>2020</year><volume>11</volume><fpage>8055</fpage><lpage>8072</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXhsVSis7vJ</pub-id><pub-id pub-id-type="doi">10.1039/D0SC03173A</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Hu</surname><given-names>W</given-names></name></person-group><article-title xml:lang="en">Organic photodiodes and phototransistors toward infrared detection: materials, devices, and applications</article-title><source>Chem Soc Rev</source><year>2020</year><volume>49</volume><fpage>653</fpage><lpage>670</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXitlOnsLnF</pub-id><pub-id pub-id-type="doi">10.1039/C9CS00431A</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>F</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Yu</surname><given-names>G</given-names></name></person-group><article-title xml:lang="en">Materials for solar-powered water evaporation</article-title><source>Nat Rev Mater</source><year>2020</year><volume>5</volume><fpage>388</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1038/s41578-020-0182-4</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Im</surname><given-names>GB</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Bhang</surname><given-names>SH</given-names></name></person-group><article-title xml:lang="en">Inorganic nanoparticles applied as functional therapeutics</article-title><source>Adv Funct Mater</source><year>2020</year><volume>31</volume><fpage>2008171</fpage><pub-id pub-id-type="doi">10.1002/adfm.202008171</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindberg</surname><given-names>GC</given-names></name><name><surname>Lim</surname><given-names>KS</given-names></name><name><surname>Soliman</surname><given-names>BG</given-names></name><name><surname>Nguyen</surname><given-names>A</given-names></name><name><surname>Hooper</surname><given-names>GJ</given-names></name><name><surname>Narayan</surname><given-names>RJ</given-names></name><name><surname>Woodfield</surname><given-names>TB</given-names></name></person-group><article-title xml:lang="en">Biological function following radical photo-polymerization of biomedical polymers and surrounding tissues: Design considerations and cellular risk factors</article-title><source>Appl Phys Rev</source><year>2021</year><volume>8</volume><fpage>011301</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3MXhtVCqu7g%3D</pub-id><pub-id pub-id-type="doi">10.1063/5.0015093</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Lei</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Multifunctional metal-organic framework heterostructures for enhanced cancer therapy</article-title><source>Chem Soc Rev</source><year>2021</year><volume>50</volume><fpage>1188</fpage><lpage>1218</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXisFSgtb%2FN</pub-id><pub-id pub-id-type="doi">10.1039/D0CS00178C</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>P</given-names></name><name><surname>Lin</surname><given-names>JJSM</given-names></name></person-group><article-title xml:lang="en">Plasmonic gold nanovesicles for biomedical applications</article-title><source>Small Meth</source><year>2019</year><volume>3</volume><fpage>1800394</fpage><pub-id pub-id-type="doi">10.1002/smtd.201800394</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montaseri</surname><given-names>H</given-names></name><name><surname>Kruger</surname><given-names>CA</given-names></name><name><surname>Abrahamse</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Review: organic nanoparticle-based active targeting for photodynamic therapy treatment of breast cancer cells</article-title><source>Oncotarget</source><year>2020</year><volume>11</volume><fpage>2120</fpage><pub-id pub-id-type="doi">10.18632/oncotarget.27596</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holtrop</surname><given-names>T</given-names></name><name><surname>Huisman</surname><given-names>J</given-names></name><name><surname>Stomp</surname><given-names>M</given-names></name><name><surname>Biersteker</surname><given-names>L</given-names></name><name><surname>Aerts</surname><given-names>J</given-names></name><name><surname>Grébert</surname><given-names>T</given-names></name><name><surname>Partensky</surname><given-names>F</given-names></name><name><surname>Garczarek</surname><given-names>L</given-names></name><name><surname>van der Woerd</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Evolution, vibrational modes of water predict spectral niches for photosynthesis in lakes and oceans</article-title><source>Nat Ecol Evol</source><year>2020</year><volume>5</volume><fpage>55</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1038/s41559-020-01330-x</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>Z</given-names></name><name><surname>Dai</surname><given-names>WH</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Lu</surname><given-names>HT</given-names></name><name><surname>Meng</surname><given-names>XD</given-names></name><name><surname>Zhang</surname><given-names>YY</given-names></name><name><surname>Cheng</surname><given-names>YR</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Fu</surname><given-names>PC</given-names></name><name><surname>Zhang</surname><given-names>XJ</given-names></name><name><surname>Dong</surname><given-names>HF</given-names></name></person-group><article-title xml:lang="en">Algae extraction controllable delamination of vanadium carbide nanosheets with enhanced near-infrared photothermal performance</article-title><source>Angew Chem Int Ed</source><year>2020</year><volume>59</volume><fpage>6601</fpage><lpage>6606</lpage><pub-id pub-id-type="doi">10.1002/anie.201916748</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Xiao</surname><given-names>Y</given-names></name><name><surname>Wan</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>CS</given-names></name></person-group><article-title xml:lang="en">Water-splitting based and related therapeutic effects: evolving concepts, progress, and perspectives</article-title><source>Small</source><year>2020</year><volume>16</volume><fpage>2004551</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXit1alurrN</pub-id><pub-id pub-id-type="doi">10.1002/smll.202004551</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sreeja</surname><given-names>S</given-names></name><name><surname>Pesala</surname><given-names>B</given-names></name></person-group><article-title xml:lang="en">Co-sensitization aided efficiency enhancement in betanin–chlorophyll solar cell</article-title><source>Mater Renew Sustain Energy</source><year>2018</year><volume>7</volume><fpage>25</fpage><pub-id pub-id-type="doi">10.1007/s40243-018-0132-x</pub-id></mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>YY</given-names></name><name><surname>Cheng</surname><given-names>YR</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Yuan</surname><given-names>ZP</given-names></name><name><surname>Wei</surname><given-names>W</given-names></name><name><surname>Lu</surname><given-names>HT</given-names></name><name><surname>Dong</surname><given-names>HF</given-names></name><name><surname>Zhang</surname><given-names>XJ</given-names></name></person-group><article-title xml:lang="en">Two-dimensional quantum dots for biological applications</article-title><source>Nano Today</source><year>2020</year><volume>34</volume><fpage>100919</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXhsVGqsL%2FI</pub-id><pub-id pub-id-type="doi">10.1016/j.nantod.2020.100919</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ovais</surname><given-names>M</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Pramanik</surname><given-names>A</given-names></name><name><surname>Das</surname><given-names>D</given-names></name><name><surname>Mukherjee</surname><given-names>A</given-names></name><name><surname>Raza</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Designing stimuli-responsive upconversion nanoparticles that exploit the tumor microenvironment</article-title><source>Adv Mater</source><year>2020</year><volume>32</volume><fpage>2000055</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXmtVGrsbs%3D</pub-id><pub-id pub-id-type="doi">10.1002/adma.202000055</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Tahir</surname><given-names>MN</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Xia</surname><given-names>X</given-names></name><name><surname>Pan</surname><given-names>X</given-names></name></person-group><article-title xml:lang="en">A critical review on the applications and potential risks of emerging MoS<sub>2</sub> nanomaterials</article-title><source>J Hazard Mater</source><year>2020</year><volume>399</volume><fpage>123057</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXhtV2rtbnF</pub-id><pub-id pub-id-type="doi">10.1016/j.jhazmat.2020.123057</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>A</given-names></name><name><surname>Liang</surname><given-names>X</given-names></name><name><surname>Ren</surname><given-names>X</given-names></name><name><surname>Guan</surname><given-names>W</given-names></name><name><surname>Gao</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>T</given-names></name></person-group><article-title xml:lang="en">Recent progress in MXene-based materials: potential high-performance electrocatalysts</article-title><source>Adv Funct Mater</source><year>2020</year><volume>30</volume><fpage>2003437</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXhtlensb7L</pub-id><pub-id pub-id-type="doi">10.1002/adfm.202003437</pub-id></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>L</given-names></name><name><surname>Yi</surname><given-names>W</given-names></name><name><surname>Sun</surname><given-names>T</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Si</surname><given-names>J</given-names></name><name><surname>Hou</surname><given-names>X</given-names></name><name><surname>Hou</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Surface modification engineering of two-dimensional titanium carbide for efficient synergistic multitherapy of breast cancer</article-title><source>J Mater Chem B</source><year>2020</year><volume>8</volume><fpage>6402</fpage><lpage>6417</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXhtVykurzM</pub-id><pub-id pub-id-type="doi">10.1039/D0TB01084G</pub-id></mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Dong</surname><given-names>Y</given-names></name><name><surname>Jia</surname><given-names>Z</given-names></name><name><surname>Di</surname><given-names>W</given-names></name><name><surname>Qin</surname><given-names>G</given-names></name><name><surname>Qin</surname><given-names>W</given-names></name></person-group><article-title xml:lang="en">MnO2 nanosheets as saturable absorbers for a Q-switched fiber laser</article-title><source>Opt Mater Express</source><year>2020</year><volume>10</volume><fpage>3097</fpage><lpage>3106</lpage><pub-id pub-id-type="doi">10.1364/OME.409592</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slattery</surname><given-names>RA</given-names></name><name><surname>VanLoocke</surname><given-names>A</given-names></name><name><surname>Bernacchi</surname><given-names>CJ</given-names></name><name><surname>Zhu</surname><given-names>X-G</given-names></name><name><surname>Ort</surname><given-names>DR</given-names></name></person-group><article-title xml:lang="en">Photosynthesis, light use efficiency, and yield of reduced-chlorophyll soybean mutants in field conditions</article-title><source>Front Plant Sci</source><year>2017</year><volume>8</volume><fpage>549</fpage><pub-id pub-id-type="doi">10.3389/fpls.2017.00549</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>C</given-names></name><name><surname>Ou</surname><given-names>M</given-names></name><name><surname>Cheng</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Xia</surname><given-names>D</given-names></name><name><surname>Mei</surname><given-names>L</given-names></name><name><surname>Ji</surname><given-names>X</given-names></name></person-group><article-title xml:lang="en">Z-scheme heterojunction functionalized pyrite nanosheets for modulating tumor microenvironment and strengthening photo/chemodynamic therapeutic effects</article-title><source>Adv Funct Mater</source><year>2020</year><volume>30</volume><fpage>1906466</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXitVSlsrnO</pub-id><pub-id pub-id-type="doi">10.1002/adfm.201906466</pub-id></mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SB</given-names></name><name><surname>Bisson</surname><given-names>J</given-names></name><name><surname>Friesen</surname><given-names>JB</given-names></name><name><surname>Pauli</surname><given-names>GF</given-names></name><name><surname>Simmler</surname><given-names>CJ</given-names></name></person-group><article-title xml:lang="en">Selective chlorophyll removal method to “degreen” botanical extracts</article-title><source>J Nat Prod</source><year>2020</year><volume>83</volume><issue>6</issue><fpage>1846</fpage><lpage>1858</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXpsV2qtbg%3D</pub-id><pub-id pub-id-type="doi">10.1021/acs.jnatprod.0c00005</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y-W</given-names></name><name><surname>Shie</surname><given-names>M-Y</given-names></name><name><surname>Hsiao</surname><given-names>C-H</given-names></name><name><surname>Liang</surname><given-names>Y-C</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>I-WP</given-names></name></person-group><article-title xml:lang="en">Synthesis of high-quality monolayer tungsten disulfide with chlorophylls and its application for enhancing bone regeneration</article-title><source>2D Mater Appl</source><year>2020</year><volume>4</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/s41699-019-0135-1</pub-id></mixed-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Lv</surname><given-names>F</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Lu</surname><given-names>H</given-names></name><name><surname>Zada</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>S</given-names></name><name><surname>Dong</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name></person-group><article-title xml:lang="en">Pd@Au bimetallic nanoplates decorated mesoporous MnO<sub>2</sub> for synergistic nucleus-targeted NIR-II photothermal and hypoxia-relieved photodynamic therapy</article-title><source>Adv Health Mater.</source><year>2020</year><volume>2</volume><fpage>e1901528</fpage><pub-id pub-id-type="doi">10.1002/adhm.201901528</pub-id></mixed-citation></ref></ref-list></ref-list><app-group><app id="App1" specific-use="web-only"><sec id="Sec23"><title>Supplementary Information</title><p id="Par50"><supplementary-material content-type="local-data" id="MOESM1" xlink:title="Supplementary Information"><media mimetype="application" mime-subtype="msword" xlink:href="MediaObjects/12951_2022_1331_MOESM1_ESM.docx" position="anchor"><caption xml:lang="en"><p><bold>Additional file 1: Scheme S1</bold>. Schematic elastration of ROS production mechanism. <bold>Figure S1</bold>. A, B and C The comparison of standard and extracted Chlorophyll (Chl) and confirm the loading Chl on V2C. Scheme S1: The ROS production mechanism scheme. <bold>Figure S2</bold>. Zeta potential analysis. <bold>Figure S3</bold>. A, B and C: The EDX analysis. <bold>Figure S4</bold>. A, B and C: Loading efficiency of of chlorophyll (Chl) on V2C SNs. (B) temperature increasing (Chl) and (C) oxygen generation measurement with various loading concentration of Chl. <bold>Figure S5</bold>. A, B: To measure the photothermal conversion efficiency of Chl/V2C NSs. <bold>Figure S6</bold>. Cell viabilities performance of Chl/V2C for different cell lines. <bold>Figure S7</bold>. A, B: The intracellular and hypoxia quantification analysis of Chl/V2C. <bold>Figure S8</bold>. A, B: Biodistribution and) Blood circulation of Mg concentrations measured. <bold>Figure S9</bold>. Hypoxia analysis of tumours untreated and treated with Chl/V2C SNs. <bold>Figure S10</bold>. Statistical analysis Ki-67 A and B TUNEL assessment of all the tumors.</p></caption></media></supplementary-material></p></sec></app></app-group><glossary><title>Abbreviations</title><def-list><def-item><term>PTT</term><def><p id="Par2">Photothermal therapy</p></def></def-item><def-item><term>PTT</term><def><p id="Par3">Photodynamic therapy</p></def></def-item><def-item><term>Chl</term><def><p id="Par4">Chlorophyll</p></def></def-item><def-item><term>V<sub>2</sub>C</term><def><p id="Par5">Vanadium carbide</p></def></def-item><def-item><term>PSs</term><def><p id="Par6">Photosensitizers</p></def></def-item><def-item><term>2D</term><def><p id="Par7">Two-dimensional</p></def></def-item><def-item><term>TBL</term><def><p id="Par8">Total bilirubin</p></def></def-item><def-item><term>AST</term><def><p id="Par9">Aspartate aminotransferase</p></def></def-item><def-item><term>ALT</term><def><p id="Par10">Alanine aminotransferase</p></def></def-item><def-item><term>BUN</term><def><p id="Par11">Blood urea nitrogen</p></def></def-item><def-item><term>GLOB</term><def><p id="Par12">Globulin</p></def></def-item><def-item><term>TP</term><def><p id="Par13">Total protein</p></def></def-item><def-item><term>CREA</term><def><p id="Par14">Creatinine</p></def></def-item><def-item><term>ALB</term><def><p id="Par15">Albumin</p></def></def-item><def-item><term>TME</term><def><p id="Par16">Tumor microenvironment</p></def></def-item><def-item><term>nm</term><def><p id="Par17">Nano meter</p></def></def-item><def-item><term>μm</term><def><p id="Par18">Micro meter</p></def></def-item><def-item><term>TEM</term><def><p id="Par19">Transmission electron microscopy</p></def></def-item><def-item><term>EDX</term><def><p id="Par20">Energy dispersive X-ray spectroscopy spectra</p></def></def-item><def-item><term>FTIR</term><def><p id="Par21">Fourier transform infrared spectroscopy</p></def></def-item><def-item><term>DLS</term><def><p id="Par22">Dynamic light scattering</p></def></def-item><def-item><term>CLSM</term><def><p id="Par23">Confocal laser scanning microscopy</p></def></def-item></def-list></glossary><notes notes-type="Misc"><title>Publisher's Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></notes></back></article></records><facets><facet name="subject"><facet-value count="1">Biotechnology</facet-value><facet-value count="1">Chemistry</facet-value><facet-value count="1">Molecular Medicine</facet-value><facet-value count="1">Nanotechnology</facet-value></facet><facet name="keyword"><facet-value count="1">Chlorophyll</facet-value><facet-value count="1">Optically active nanostructures</facet-value><facet-value count="1">Photodynamic therapy</facet-value><facet-value count="1">Photothermal therapy</facet-value><facet-value count="1">Vanadium carbide</facet-value></facet><facet name="pub"><facet-value count="1">Journal of Nanobiotechnology</facet-value></facet><facet name="year"><facet-value count="1">2022</facet-value></facet><facet name="country"><facet-value count="1">China</facet-value></facet><facet name="type"><facet-value count="1">Journal</facet-value></facet></facets></response>
